Samuel Arbesman - Profile and Investment Details

Investor Profile

Samuel Arbesman is a Venture Capital, Entrepreneurship Program, Private Equity Firm based in United States with a diverse investment portfolio that includes companies such as Auris Health, Workit Health, OpenSpace, Science 37, Statespace, Mos, Roam Research, Orbital Insight, Strangeworks, Kallyope, Hugging Face, SteadyMD, Saildrone, Avail Medsystems, Lightform, Nozomi Networks, ZEDEDA, Chronosphere, Rosebud AI, neo.tax, Fiddler AI, EchodyneAnduril Industries, SkySelect, Flex Logix Technologies, Latch, Mahana Therapeutics, Elektra Labs, H1, Anchorage, Primer, Mythic, Vium, Evolv Technology, Vesta Healthcare, Somatic Labs, Cape Analytics, Visla Labs, Paceline, Survios, CTRL-labs, Ahana, Shiru, Pager, Onaroll, Runway, Thrive Earlier Detection, Ripcord, Kyruus, Benchling, Pivotal Commware, EverlyWell, Tempo Automation, CryptoNumerics, Common Networks, Shadow, Arraiy, Looking Glass Factory, Applied Intuition, LabGenius, Cala Health, Yonder, Aeva, Zipdrug, Caper, Varda, Higharc, Recursion Pharmaceuticals, Variant Bio, Braid Health, Matterport, Plexium, Senti Biosciences, Rivet, AllStripes, Decent, Novel Effect, Shapeways, . Over time, Samuel Arbesman has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Samuel Arbesman is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Emerging Technology, Wellness, Women Founded, Android, Life Science, Artificial Intelligence (AI), Robotics, Startups, Science, Information Technology (IT), Internet of Things (IoT), Architecture, Software, Manufacturing, Biotechnology, Construction, Productivity Software, Consumer Internet, Pets, Logistics, Social Impact, Nanotechnology, Medical, Real Estate, Media and Entertainment, Machine Learning, Personal Health, Air Transportation, Pharmaceuticals may find it worthwhile to explore potential connections with Samuel Arbesman, as their portfolio suggests a familiarity and interest in this area.

Understanding Samuel Arbesman’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.